Rare diseases
Investigational molecules
Locations
Study of the efficacy and safety of inclisiran and a drug combination in patients with acute coronary syndrome
FranceA study to evaluate the effectiveness of AZD5148 in preventing the recurrence of Clostridioides difficile infection in adults.
FranceStudy of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes
FranceA study to evaluate the safety and effectiveness of tafasitamab in adults with autoimmune thrombocytopenia or autoimmune hemolytic anemia
FranceA study to evaluate the safety and effectiveness of H-CYS(SS)-GLU-VAL-SER-GLN-LEU-LEU-LYS-GLY-ASP-ALA-CYS(SS)-OH in patients with advanced solid tumors who have completed other treatments.
FranceA study of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in adults with newly diagnosed multiple myeloma not eligible for transplant
FranceA study to evaluate the safety and effectiveness of BNT324 and BNT327 in patients with advanced lung cancer
FranceA study comparing the effectiveness and safety of datopotamab deruxtecan and docetaxel in adults with advanced or metastatic non-squamous non-small cell lung cancer
FranceA study to evaluate the effectiveness of ciracigene golparvovec in children with Canavan disease
FranceFranceA study to evaluate the long-term safety and effectiveness of mRNA-3927 in patients with Propionic Acidemia
FranceA study of enzomenib in adult patients with relapsed or refractory acute leukemia, including those with MLL rearrangement or NPM1 mutation.
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
